DIBUCAINE 1% HEMORRHOIDAL OINTMENT, 1 oz. (28 gm), Manufactured for: Akron Pharma Inc. Fairfield NJ 07004, NDC 71399-2829-1
Published March 15, 2023 · Recall initiated: February 17, 2023
Summary
FDA records drug Class III recall D-0454-2023, published March 15, 2023 and initiated February 17, 2023. Recalling firm: Akron Pharma, Inc.; Status: Terminated; Reported quantity: 4,416 tubes; Lot: Lot #: 2206016, Exp. date 05/2024. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Labeling: Incorrect or Missing Lot and/or Exp Date
What to do
Voluntary: Firm initiated · Letter
Get an email if DIBUCAINE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- DIBUCAINE
- Manufacturer
- Akron Pharma, Inc.
- Distributor
- Nationwide within the United States
- Lot
- Lot #: 2206016, Exp. date 05/2024
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAUnguentine Original Maximum Strength Pain Relieving/Antiseptic Ointment (Camphor 3.0%, Phenol 2.5%, TannicMarch 15, 2023
- FDASnowy Range Blue Alcohol Antiseptic 80% Topical Solution Hand Sanitizer Non-Sterile Solution, 4fl. oz.March 15, 2023
- FDAActivator Concentrate (sodium fluoride 0.96% in Activator) 1 fl. Oz, liquid oral rinse plastic bottles,March 15, 2023
- FDAPurely Soothing 15% MSM Drops, packaged in a)15 ml, .5 fl oz bottle, UPC 7 31034 91382 9; and b) 30 ml, 1.014March 15, 2023
- FDANose Better Gel (0.75% Camphor, 0.50% Menthol, 0.50% Allantoin), packaged in 0.46 oz. (13g) metal tubes,March 15, 2023
- FDAPurely Soothing MSM Nasal Spray, 15%, packaged in 30ml, 1.014 fl. oz bottles, Manufactured by: Pharmedica USA,March 15, 2023
Questions about this recall
Was DIBUCAINE 1% HEMORRHOIDAL OINTMENT, 1 oz. (28 gm), Manufactured for: Akron Pharma Inc. Fairfield NJ 07004, NDC 71399-2829-1 recalled?
Yes. FDA published recall D-0454-2023 on March 15, 2023. Reported hazard: Labeling: Incorrect or Missing Lot and/or Exp Date
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: DIBUCAINE.